Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen…

Overview of attention for article published in Antimicrobial Resistance & Infection Control, October 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 10 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 Studies

Article in Surgical Infections (November 2020)

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)

Article in Antimicrobial Resistance & Infection Control (December 2019)

The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections

Article in Expert Opinion on Pharmacotherapy (September 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.